SINOHEALTH HLDG (02361) Achieves Significant Progress in Commercialization of AI Large Models and AI Agents, Successfully Transforms into AI Tech Service Provider

Stock News
2025/12/24

SINOHEALTH HLDG (02361) announced that, as of the date of this announcement, the company has made notable advancements in the commercial application of AI large models and AI agents. Its AI services and products now cover marketing, healthcare, pharmacies, and consumer management scenarios, reaching a comprehensive health industry collaboration network encompassing "medical, pharmaceutical, and patient" sectors.

In marketing, the company has launched the "AI Marketing Lab" and introduced the "Tiangong-1 Commercial AI Agent," providing "+AI" digital intelligence solutions to 182 pharmaceutical companies. These solutions empower enterprises to achieve rapid responses, efficient decision-making, and action in dynamic environments.

In healthcare, leveraging its self-developed "Zhumuniao Medical Large Model," the company has rolled out the "iMDT" intelligent agent for multidisciplinary team consultations on severe diseases. It has served 512 hospitals and assisted over 1,520 clinicians in complex medical diagnoses, significantly improving the decision-making quality of multidisciplinary teams (MDT).

In the pharmacy sector, the company's pharmacy AI agent has been adopted by more than 10,993 pharmacies. Utilizing comprehensive industry data, the company has established a five-matrix AI agent system covering operational insights, products, diseases, members, and staff, along with specialized AI for "individuals, families, diseases, and medication," enhancing store operations.

In health management, the company has built an AI agent matrix targeting "individuals, families, disease types, and medication," precisely serving over 3 million users. It provides personalized health interventions and risk alerts, forming a full-cycle management system that includes prevention, screening, and intervention.

The disclosed business data confirms the company's successful transition from a data technology service provider to an AI-driven tech service provider. SINOHEALTH HLDG will continue refining its "data + model + scenario + ecosystem" capabilities, striving to become the preferred AI service provider in the health industry.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10